-
241
Absent in melanoma 2: a potent suppressor of retinal pigment epithelial-mesenchymal transition and experimental proliferative vitreoretinopathy
Published 2025-01-01“…It also contributes to retinal diseases, such as age-related macular degeneration (AMD) and proliferative vitreoretinopathy (PVR). …”
Get full text
Article -
242
The effect of blue-blocking intraocular lenses on circadian biological rhythm: protocol for a randomised controlled trial (CLOCK-IOL colour study)
Published 2015-05-01“…Meanwhile, blue light causes photochemical damage to the retina, and may be associated with age-related macular degeneration (AMD). At present, clear intraocular lenses (IOLs) and blue-blocking IOLs are both widely used for cataract surgery; there is currently a lack of randomised controlled trials to determine whether clear or blue-blocking IOLs should be used.Methods and analysis This randomised controlled trial will recruit 1000 cataract patients and randomly allocate them to receive clear IOLs or blue-blocking IOLs in a ratio of 1:1. …”
Get full text
Article -
243
Solitary vitreous cysts: a series of case reports
Published 2024-09-01“…In one case, bilateral vitreous cysts were identified in conjunction with agerelated macular degeneration. To the best of our knowledge, this represents the inaugural description of this association. …”
Get full text
Article -
244
Effect of intravitreal injections on the progression and prognosis of primary open-angle glaucoma
Published 2021-12-01“…., age-related macular degeneration (AMD), diabetic macular edema, retinal vein occlusion, choroidal inflammatory diseases, and pathologic myopia. …”
Get full text
Article -
245
Therapeutic applications of artemisinin in ophthalmic diseases
Published 2025-01-01“…To better explore and perfect the mechanism of action of artemisinin in ophthalmic diseases, and to better promote the clinical application of artemisinin, this study reviews the latest progress of artemisinin treatment for uveitis, uveal melanoma, age-related macular degeneration, diabetic retinopathy, ocular neovascularization, and dry eye, and it will provide theoretical support for the large-scale application of artemisinin in ophthalmic diseases in the future.…”
Get full text
Article -
246
Co-isolation of human donor eye cells and development of oncogene-mutated melanocytes to study uveal melanoma
Published 2025-01-01“…The co-isolated RPE cells could benefit research on other ocular pathologies, such as age-related macular degeneration. Graphical Abstract Created with https://www.biorender.com/ .…”
Get full text
Article -
247
EyeLiner
Published 2025-03-01“…Objective: Detecting and measuring changes in longitudinal fundus imaging is key to monitoring disease progression in chronic ophthalmic diseases, such as glaucoma and macular degeneration. Clinicians assess changes in disease status by either independently reviewing or manually juxtaposing longitudinally acquired color fundus photos (CFPs). …”
Get full text
Article -
248
Extensive Macular Atrophy with Pseudodrusen Imaged with OCT Angiography
Published 2018-01-01“…Extensive macular atrophy with pseudodrusen is a rare clinical entity and a new extreme phenotype of macular degenerations that could shed more light on the role of pseudodrusen and choriocapillaris compromise in the pathogenesis of AMD.…”
Get full text
Article